Skip to content
About
Clinical Trials
Resources
Contact
About
Clinical Trials
Resources
Contact
Trial Type: Liver
Sub-categories
All Gastrointestinal
↳
Colon
↳
Esophagus
↳
Liver
↳
Other Digestive Organ
↳
Pancreas
↳
Rectum
↳
Stomach
BRUOG-430
A Phase II Pilot Study of yttriuM-90 in Combination With capEcitabine and aTezolizumab for oligomEtastatic cOlorectal Cancer With unResectable lIver MeTastasEs (METEORITE)
Protocol Status: OPEN TO ACCRUAL
Trial Type:
Colon
,
Gastrointestinal
,
Liver
,
Rectum
Contact: Raufi, Alexander
araufi2@BrownHealth.org